Tazidem Indications/Uses

Susceptible organisms: Methicillin-susceptible Staphylococcus aureus, Methicillin-susceptible Staphylococcus epidermidis, Micrococcus, Streptococcus pyogenes (Group A beta (β) hemolytic), Streptococcus agalactiae (Group B), Streptococcus viridans, Streptococcus (Except Enterococcus), Streptococcus pneumoniae, Pseudomonas spp. (Pseudomonas aeruginosa), Klebsiella spp (Klebsiella pneumonia, etc.), Proteus mirabilis, Proteus vulgaris, Morganella morganii, Proteus Providencia rettgeri, Providencia, Escherichia coli, Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitis, Pathogenic bacterium of animal pasteurellosis, Acinetobacter, Neisseria gonorrhoeae, Neisseria meningitidis, Hemophilus influenzae (including Ampicillin-resistant strains), Parainfluenza virus (including Ampicillin-resistant strains), Peptococcus, Peptostreptococcus, Propionibacterium, Clostridium perfrigens, Fusobacterium, Bacteroid (except Bacteroides fragilis).
Uses: Sepsis, Meningitis; Pneumonia, Pleuritis, Emphysema, Pulmonary abscess, Bronchiectasis (in infection), Bronchitis, Pulmonary infection in patients with cystic fibrosis; Otitis media, Malignant external otitis, Mastoiditis, Sinusitis, Severe infection in ear or throat part; Pyelonephritis, Prostatitis, Cystitis, Urethritis; Erysipelas, Abscess, Secondary infection after trauma or burn, Mastitis, Dermal ulcer; Cholangitis, Cholecystitis, Empyema of gallbladder, Intra-abdominal abscess, Peritonitis, Diverticulitis, Enterocolitis, Pelvic infection; Osteomyelitis, Ostitis, Septic arthritis, Infectious bursitis; Severe infections in the immunocompromised patient, Severe infection including burn infection, Infection due to hemodialysis or Intraperitoneal dialysis, Infection associated with CAPD.